Why Is Perrigo (PRGO) Down 3.1% Since Last Earnings Report?

Core Viewpoint - Perrigo's shares have declined approximately 3.1% since the last earnings report, underperforming the S&P 500, raising questions about the potential for a breakout or continued negative trend leading up to the next earnings release [1] Group 1: Earnings Estimates - Fresh estimates for Perrigo have trended downward over the past month, with the consensus estimate shifting down by 5.22% [2] - The overall direction and magnitude of estimate revisions indicate a downward shift in expectations for the stock [4] Group 2: VGM Scores - Perrigo has a subpar Growth Score of D and a similar score for momentum, but it received an A grade for value, placing it in the top quintile for this investment strategy [3] - The aggregate VGM Score for Perrigo is B, which is relevant for investors not focused on a single strategy [3] Group 3: Industry Performance - Perrigo is part of the Zacks Medical - Products industry, where GE HealthCare Technologies has gained 1.5% over the past month, reporting revenues of $4.78 billion, a year-over-year increase of 2.7% [5] - GE HealthCare's expected earnings for the current quarter are $0.91 per share, reflecting a 9% decrease from the previous year, with a Zacks Rank of 4 (Sell) and a VGM Score of C [6]